USPTO serial 90575161
CHIRON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 15, 2025
- Examiner
- YOUNG, THOMAS PAUL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CHIRON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
GRIFOLS DIAGNOSTIC SOLUTIONS INC.
EMERYVILLE, CA
GRIFOLS DIAGNOSTIC SOLUTIONS INC.
EMERYVILLE, CA
GRIFOLS DIAGNOSTIC SOLUTIONS INC.
EMERYVILLE, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashly I. Boesche
Ashly I. Boesche PATTISHALL, MCAULIFFE, NEWBURY, HILLIARD & GERALDS200 S. WACKER DRIVE, SUITE 2900CHICAGO, IL 60606United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for use in industry; chemicals used in science; reagents for scientific purposes; diagnostic preparations, namely, antigens and antibodies for scientific purposes; testing kits for scientific purposes predominantly consisting of reagents; proteins for industrial use, namely, antigens and antibodies; nucleic acids for laboratory use, namely, nucleic acid for the production of proteins produced by biochemical and/or genetic engineering methods | ACTIVE | Jan 31, 2014 |
| 005 | Antibacterial pharmaceuticals; diagnostic veterinary preparations; diagnostic preparations for medical purposes; diagnostic preparations, namely, antigens and antibodies for medical purposes for use in disease testing; pharmaceutical, veterinary and/or diagnostic preparations and substances produced by biochemical and/or genetic engineering methods, namely, antivirals and diagnostic preparations for veterinary and medical use; reagents for medical purposes; tests and test kits for medical and pharmaceutical purposes, namely, drug testing kits comprised of medical diagnostic reagents and assays that testing bodily fluids | ACTIVE | Jan 31, 2014 |
| 040 | Custom manufacture of pharmaceutical, veterinary and diagnostic preparations and substances; custom manufacture of biopharmaceuticals; biomanufacturing for others, namely, processing of biopharmaceutical materials for others; consultancy services relating to manufacturing processes for pharmaceutical, veterinary and diagnostic substances; custom manufacture of recombinant proteins | ACTIVE | Dec 31, 2023 |
| 042 | Scientific and technological services, namely, pharmaceutical and new product research and design; scientific research and development services; research in the chemical, medical, and/or biochemical field; development of pharmaceutical, veterinary medicine and medical diagnostic substances and products and pharmaceutical research regarding methods for the manufacture thereof, namely, using biotechnological and genetically-engineered means; process development services in relation to pharmaceutical, veterinary and diagnostic substances, namely, consulting regarding the development of pharmaceutical preparations and medicines; technical consultancy in the pharmaceutical, veterinary and diagnostic sector, namely, technical consulting in the field of pharmaceutical studies; new product development services in relation to recombinant protein technology and development | ACTIVE | Dec 31, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GRIFOLS DIAGNOSTIC SOLUTIONS INC.
- Other trademarks owned by GRIFOLS DIAGNOSTIC SOLUTIONS INC.
- Other trademarks owned by GRIFOLS DIAGNOSTIC SOLUTIONS INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named CHIRON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 15, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 15, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 21, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 21, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 20, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 20, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 16, 2025 | IUAF | USE AMENDMENT FILED | — |
| Jan 16, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 13, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 31, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 31, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 31, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 11, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 9, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jan 9, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 9, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 19, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 17, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 17, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 17, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 13, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 11, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 11, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 11, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 14, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 14, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 14, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 18, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 20, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 20, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 20, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 20, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2021 | NWAP | NEW APPLICATION ENTERED | — |